Lupin Digital Health, a wholly-owned subsidiary of global pharmaceutical giant Lupin Limited, announced the launch of its digital therapeutics solution, LYFE.
LYFE is India’s only evidence-based holistic heart care program that significantly reduces the risk of a heart attack while also improving cardiac patients’ vitals and quality of life.
LYFE, designed by leading Indian cardiologists, assists patients in improving their heart health through doctor-connected online and offline modules. Wearable devices that have been approved by the FDA and the CE record vital parameters and alert carers and doctors to out-of-range vitals and emergencies.
Rajeev Sibal, President of India Region Formulations at Lupin stated, ‘LYFE harnesses the power of human intelligence and AI/ML to enhance doctor-patient collaboration, monitor health vitals, increase patient awareness, and promote therapy adherence. With LYFE, Lupin aims to provide a holistic solution for heart care and reduce uncertainty for patients.’
LYFE’s simple and intuitive interface provides medication reminders, as well as emergency and ambulance assistance 24 hours a day, seven days a week.
LYFE also provides expert intervention through dedicated care managers, health coaches, and nutritionists. LYFE is a complete solution for cardiac patients that adheres to protocols designed by their treating cardiologists.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.